A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants

NCT06710925 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

315

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL: TNM001
BIOLOGICAL: placebo

Sponsor

Zhuhai Trinomab Pharmaceutical Co., Ltd.